Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2639)
All Articles published online
|
Aug 1, 2004 (publication date) through Dec 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zou SQ, Qu ZL, Li ZF, Wang X. Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. World J Gastroenterol 2004; 10(15): 2259-2262 [PMID: 15259077 DOI: 10.3748/wjg.v10.i15.2259] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i15/2259.htm |
| Number | Citing Articles |
| 1 |
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2): 253 doi: 10.1016/j.canlet.2016.02.038
|
| 2 |
Sally Temraz, Ali T. Taher. Liver Cancer in the Middle East. 2021; : 375 doi: 10.1007/978-3-030-78737-0_24
|
| 3 |
Tae Y. Lee, Sang S. Lee, Seok W. Jung, Seong H. Jeon, Sung-Cheol Yun, Hyoung-Chul Oh, Seunghyun Kwon, Sung K. Lee, Dong W. Seo, Myung-Hwan Kim, Dong J. Suh. Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study. The American Journal of Gastroenterology 2008; 103(7): 1716 doi: 10.1111/j.1572-0241.2008.01796.x
|
| 4 |
Yun-Feng Wang, Ke-Jian Guo, Bei-Ting Huang, Yong Liu, Xiao-Yun Tang, Jian-Jun Zhang, Qiang Xia. Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth <italic>in vitro</italic>. World Journal of Gastroenterology 2006; 12(25): 4004-4008 doi: 10.3748/wjg.v12.i25.4004
|
| 5 |
Zhenliang QU, Naiqiang CUI, Mingfang QIN, Xianzhong WU. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Asia-Pacific Journal of Clinical Oncology 2012; 8(1): 83 doi: 10.1111/j.1743-7563.2011.01466.x
|
| 6 |
Caixia Wang, Haiyan Jing, Dan Sha, Weibo Wang, Jianpeng Chen, Yangang Cui, Junqing Han. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1643-7
|
| 7 |
Enakshi Sivasudhan, Neil Blake, Zhiliang Lu, Jia Meng, Rong Rong. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. Cells 2022; 11(4): 741 doi: 10.3390/cells11040741
|
| 8 |
Yan-Ming Zhou, Zheng-Feng Yin, Jia-Mei Yang, Bin Li, Wen-Yu Shao, Feng Xu, Yu-Lan Wang, Dian-Qi Li. Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World Journal of Gastroenterology 2008; 14(4): 632-635 doi: 10.3748/wjg.14.632
|
| 9 |
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology 2012; 27(10): 1561 doi: 10.1111/j.1440-1746.2012.07207.x
|
| 10 |
M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. Journal of Viral Hepatitis 2010; 17(10): 742 doi: 10.1111/j.1365-2893.2009.01243.x
|
| 11 |
Jiun‐Ming Su, Xiang‐Me Lai, Keng‐Hsin Lan, Chung‐Pin Li, Yee Chao, Sang‐Hue Yen, Full‐Young Chang, Shou‐Dong Lee, Wei‐Ping Lee. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter†. Hepatology 2007; 46(2): 402 doi: 10.1002/hep.21675
|
| 12 |
Manale El Idrissi, Valérie Hervieu, Philippe Merle, Franck Mortreux, Eric Wattel. Cause-specific telomere factors deregulation in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-64
|
| 13 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 14 |
Young‐Joo Kim, Jeong Eun Yoo, Youngsic Jeon, Jae Uk Chong, Gi Hong Choi, Dae‐Geun Song, Sang Hoon Jung, Bong‐Kyeong Oh, Young Nyun Park. Suppression of PROX1‐mediated TERT expression in hepatitis B viral hepatocellular carcinoma. International Journal of Cancer 2018; 143(12): 3155 doi: 10.1002/ijc.31731
|
| 15 |
Mahamud‐ur Rashid, Kevin M. Coombs. Serum‐reduced media impacts on cell viability and protein expression in human lung epithelial cells. Journal of Cellular Physiology 2019; 234(6): 7718 doi: 10.1002/jcp.27890
|
| 16 |
Ali Salimi-Jeda, Fariba Badrzadeh, Maryam Esghaei, Asghar Abdoli. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches. Cancer Treatment and Research Communications 2021; 27: 100323 doi: 10.1016/j.ctarc.2021.100323
|
| 17 |
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. International Journal of Molecular Sciences 2019; 20(6): 1358 doi: 10.3390/ijms20061358
|
| 18 |
Vivekanandan Perumal, Jianzhou Wang, Paul Thuluvath, Michael Choti, Michael Torbenson. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Human Pathology 2006; 37(9): 1211 doi: 10.1016/j.humpath.2006.04.012
|
| 19 |
Lei Zhang, Jian‐Qiang Cai, Jian‐Jun Zhao, Xin‐Yu Bi, Xiao‐Gang Tan, Tao Yan, Cong Li, Ping Zhao. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2010; 101(3): 233 doi: 10.1002/jso.21488
|
| 20 |
D. Nart, Y. Ertan, E.E. Pala, M. Zeytunlu, M. Kilic, F. Yilmaz. Intrahepatic Cholangiocarcinoma Arising in Chronic Viral Hepatitis–Associated Cirrhosis: Two Transplant Cases. Transplantation Proceedings 2008; 40(10): 3813 doi: 10.1016/j.transproceed.2008.06.071
|
| 21 |
Roberto Filippi, Giovanni Brandi, Andrea Casadei-Gardini, Francesco Leone, Nicola Silvestris, Maria Antonietta Satolli, Francesca Salani, Elisa Sperti, Stefania Eufemia Lutrino, Giuseppe Aprile, Daniele Santini, Mario Scartozzi, Luca Faloppi, Andrea Palloni, Marzia Deserti, Simona Tavolari, Margherita Rimini, Oronzo Brunetti, Rosella Spadi, Depetris Ilaria, Massimo Di Maio. Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance. Cancer Investigation 2024; : 1 doi: 10.1080/07357907.2024.2432013
|
| 22 |
Chang Liu, Qinghai Dai, Qian Ding, Min Wei, Xiaohong Kong. Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA. Infectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00357-4
|
| 23 |
Amy N. Depcrynski, Patrick C. Sachs, Lynne W. Elmore, Shawn E. Holt. Telomeres and Telomerase in Cancer. 2009; : 47 doi: 10.1007/978-1-60327-879-9_3
|
| 24 |
Deepa Rajagopalan, Amit Kumar Pandey, Magdalene Claire Xiuzhen, Kwok Kin Lee, Shainan Hora, Yanzhou Zhang, Boon Haow Chua, Hui Si Kwok, Shreshtha Sailesh Bhatia, Lih Wen Deng, Daniel G. Tenen, Dennis Kappei, Sudhakar Jha, Robert F. Kalejta. TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter. PLOS Pathogens 2017; 13(10): e1006681 doi: 10.1371/journal.ppat.1006681
|
| 25 |
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinoma. Journal of Viral Hepatitis 2013; 20(5): 297 doi: 10.1111/jvh.12093
|